DIALYSIS · CCN 332686

USRC CHEEKTOWAGA DIALYSIS

CHEEKTOWAGA, NY 14227

DialysisProfitUS Renal Care, Inc.
$5.7M
TOTAL REVENUE
11.2%
OPERATING MARGIN
3 / 5
STAR RATING
16
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.7M
Total costs
$5.1M
Operating income (rev − costs)
$639K
Operating margin
11.2%
Total charges
$5.7M
Total treatments
13,652
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

16 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9371—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9924—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.3465—
Fistula Rate
DFC_FISTULA_RATE
5783—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
3.7150—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
151.189—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
0101—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.14——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2983—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
24.4375—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
16.872—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
2484—
Standardized ED Visits Ratio
DFC_SEDR
0.8341—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
42.731—